Claro Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$751K Buy
1,113
+331
+42% +$197K 0.07% 226
2026
Q2
$392K Sell
782
-6
-0.8% -$2.88K 0.04% 331
2026
Q1
$387K Buy
788
+17
+2% +$9.23K 0.05% 303
2025
Q4
$447K Buy
771
+40
+5% +$22.6K 0.06% 247
2025
Q3
$355K Sell
731
-7
-0.9% -$3.26K 0.05% 285
2025
Q2
$299K Sell
738
-284
-28% -$119K 0.05% 293
2025
Q1
$508K Buy
1,022
+122
+14% +$66.1K 0.07% 260
2024
Q4
$468K Sell
900
-399
-31% -$219K 0.06% 256
2024
Q3
$804K Buy
1,299
+558
+75% +$330K 0.1% 191
2024
Q2
$410K Buy
741
+148
+25% +$84.8K 0.06% 261
2024
Q1
$345K Buy
+593
New +$333K 0.06% 296
2019
Q1
– Sell
-146
Closed -$36K – 855
2018
Q4
$36K Buy
+146
New +$34.3K 0.03% 408

Other funds holding TMO

Claro Advisors's TMO Position: Q3 2026 in Review

Claro Advisors increased its Thermo Fisher Scientific (TMO) stake by 42% in Q3 2026, buying an estimated $197K and bringing the position to 1,113 shares worth $751K. The position accounts for 0.07% of the portfolio, ranked #226.

Claro Advisors first reported a position in TMO in Q4 2018 and has held it in 12 quarters since. The position peaked at $804K in Q3 2024. 2,780 funds tracked by Wall St. Rank hold TMO as of Q3 2026.

  • Claro Advisors held 1,113 shares of Thermo Fisher Scientific worth $751K as of Q3 2026.
  • Claro Advisors bought 331 Thermo Fisher Scientific shares in Q3 2026, an estimated $197K.
  • Thermo Fisher Scientific made up 0.07% of Claro Advisors's portfolio in Q3 2026, its #226 holding.
  • Claro Advisors first reported a position in Thermo Fisher Scientific in Q4 2018 and has held it in 12 quarters since.
  • Claro Advisors's Thermo Fisher Scientific position peaked at $804K in Q3 2024.
  • 2,780 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q3 2026.

Based on Claro Advisors's 13F filing for Q3 2026, filed 2 Nov 2026.